RACHEL SULFRIDGE: Open Payments
NPI 1144951989 · NAPERVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,068 in 209 payments from 21 companies in 2025. Trend: 2023 $2,581 · 2024 $3,692 · 2025 $5,068
Food & beverage: $4,963Education: $105
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $936 |
| ABBVIE INC. | 34 | $694 |
| Galderma Laboratories, L.P. | 35 | $441 |
| Incyte Corporation | 18 | $427 |
| UCB, Inc. | 11 | $412 |
| GENZYME CORPORATION | 8 | $366 |
| Novartis Pharmaceuticals Corporation | 11 | $364 |
| PFIZER INC. | 11 | $235 |
| Lilly USA, LLC | 9 | $235 |
| Verrica Pharmaceuticals Inc. | 13 | $210 |
Products named: TREMFYA, OPZELURA, Bimzelx, NEMLUVIO, RINVOQ, DUPIXENT, SKYRIZI, TALTZ.
Industry payments across IL — which companies pay providers there.
